Nasdaq News

The dollar index (DXY00 ) fell by -0.32% on Friday. The dollar was under pressure Friday after WTI crude oil prices fell more than -2%, easing inflation expectations and weighing on Fed policy. Also, strength in stocks on Friday curbed liquidity demand for the dollar. Dollar losses were limited on...

(RTTNews) - Akeso, Inc. (9926.HK), a biopharmaceutical company, announced that it has enrolled the first patient in COMPASSION-37 (AK104-311), a phase 3 trial evaluating Cadonilimab as first-line treatment for patients with HER2-negative, previously untreated, unresectable or met

(RTTNews) - Indian shares were deep in the red on Monday after U.S. President Donald Trump rejected Iran's latest proposal to reopen the Strait of Hormuz and other demands.

Key PointsThe director disposed of 4,452 shares for a total transaction value of ~$171,179 on September 15, 2026.

(RTTNews) - XtalPi Holdings Limited (2228.HK), an AI- and robotics-driven drug and materials discovery company, announced the submission of an Investigational New Drug (IND) application to the U.S. FDA for KQTD-126 for chronic intestinal pain.

As Micron prepares to report Q4 earnings, the tech giant is riding high on AI-driven demand and a tight memory supply.

(RTTNews) - The Australian stock market is extending its early gains in mid-market trading on Monday, but reversing some of the losses in the previous two sessions, following the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is moving above the

(RTTNews) - PepsiCo (PEP) is preparing a major expansion in Colombia, with plans to invest $1 billion across the country over the next five years. The initiative is expected to strengthen the food and beverage company's local presence through investments in manufacturing, logisti

(RTTNews) - HUTCHMED (China) Limited (HCM) on Monday announced the initiation of the Phase 1a portion of a global clinical trial evaluating HMPL-A830 in patients with unresectable, advanced or metastatic solid tumors.

(RTTNews) - Asian stock markets are trading mixed on Monday, following the broadly positive cues from Wall Street on Friday, amid continued uncertainty over the end to the U.S.-Iran conflict after US President Donald Trump rejected Iran's latest conditional proposal to reopen the

Key PointsX-Energy and GE Vernova both develop small modular nuclear reactors.

(RTTNews) - Accuray Inc.(ARAY) announced a collaboration with Samsung HME America, operating as Samsung NeuroLogica, to explore advanced volumetric imaging capabilities for the CyberKnife radiation therapy platform.

(RTTNews) - A federal jury in San Diego awarded Taction Technology more than $5.7 billion in damages after finding that Apple infringed two patents related to haptic technology, according to media reports.

(RTTNews) - Quest PharmaTech Inc. (QPT.V), a Canadian biopharmaceutical company developing products through investee companies and proprietary technologies, announced the retirement of Madi Madiyalakan as Chief Executive Officer (CEO).

(RTTNews) - Indian shares look set to open a tad lower on Monday amid continued uncertainty over the end to the U.S.-Iran war in the Middle East.

Key PointsIt was easy to miss the $14 billion stock buyback amid Sandisk more than quadrupling its sales year over year and reaching a 77% net profit margin.

Key PointsThe transaction involved 8,500 shares executed at $245.64 per share for a total value of ~$2.1 million.

Key PointsInteractive Brokers' client accounts climbed 35% year over year as of August, over twice the pace a five-year double would require.

(RTTNews) - The Thai stock market bounced higher again on Friday, one day after ending the five-day winning streak in which it had jumped almost 50 points or 3.1 percent. The Stock Exchange of Thailand now sits just above the 1,605-point plateau and it's likely to open to the ups

(RTTNews) - Mirum Pharmaceuticals, Inc. (MIRM), a rare disease company, is scheduled to host an investor call on September 28, 2026, to share topline results from the Phase 3 AZURE-1 study of Brelovitug in patients with Chronic hepatitis delta virus.